Literature DB >> 31599367

Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia.

Rodrigo Iturriaga1, Sebastian Castillo-Galán2.   

Abstract

PURPOSE OF REVIEW: Obstructive sleep apnea (OSA), featured by chronic intermittent hypoxia (CIH), is an independent risk for systemic hypertension (HTN) and is associated with pulmonary hypertension (PH). The precise mechanisms underlying pulmonary vascular remodeling and PH in OSA are not fully understood. However, it has been suggested that lung tissue hypoxia, oxidative stress, and pro-inflammatory mediators following CIH exposure may contribute to PH. RECENT
FINDINGS: New evidences obtained in preclinical OSA models support that an enhanced carotid body (CB) chemosensory reactiveness to oxygen elicits sympathetic and renin-angiotensin system (RAS) overflow, which contributes to HTN. Moreover, the ablation of the CBs abolished the sympathetic hyperactivity and HTN in rodents exposed to CIH. Accordingly, it is plausible that the enhanced CB chemosensory reactivity may contribute to the pulmonary vascular remodeling and PH through the overactivation of the sympathetic-RAS axis. This hypothesis is supported by the facts that (i) CB stimulation increases pulmonary arterial pressure, (ii) denervation of sympathetic fibers in pulmonary arteries reduces pulmonary remodeling and pulmonary arterial hypertension (PAH) in humans, and (iii) administration of angiotensin-converting enzyme (ACE) or blockers of Ang II type 1 receptor (ATR1) ameliorates pulmonary remodeling and PH in animal models. In this review, we will discuss the supporting evidence for a plausible contribution of the CB-induced sympathetic-RAS axis overflow on pulmonary vascular remodeling and PH induced by CIH, the main characteristic of OSA.

Entities:  

Keywords:  Carotid body; Intermittent hypoxia; Obstructive sleep apnea; Pulmonary remodeling; Systemic and pulmonary hypertension

Mesh:

Year:  2019        PMID: 31599367     DOI: 10.1007/s11906-019-0995-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  99 in total

Review 1.  Neurotransmission in the carotid body: transmitters and modulators between glomus cells and petrosal ganglion nerve terminals.

Authors:  Rodrigo Iturriaga; Julio Alcayaga
Journal:  Brain Res Brain Res Rev       Date:  2004-12

2.  Significance of sympathetic innervation of pulmonary vessels in response to acute hypoxia.

Authors:  J P Szidon; J F Flint
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-07

3.  Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea.

Authors:  K Narkiewicz; P J van de Borne; N Montano; M E Dyken; B G Phillips; V K Somers
Journal:  Circulation       Date:  1998-03-17       Impact factor: 29.690

4.  Carotid body and cardiorespiratory alterations in intermittent hypoxia: the oxidative link.

Authors:  R Del Rio; E A Moya; R Iturriaga
Journal:  Eur Respir J       Date:  2009-12-08       Impact factor: 16.671

5.  The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice.

Authors:  Rachel E Nisbet; Anitra S Graves; Dean J Kleinhenz; Heidi L Rupnow; Alana L Reed; Tai-Hwang M Fan; Patrick O Mitchell; Roy L Sutliff; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-23       Impact factor: 6.914

Review 6.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

Review 7.  The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

8.  Punicalagin Prevents Hypoxic Pulmonary Hypertension via Anti-Oxidant Effects in Rats.

Authors:  Jingyun Shao; Peng Wang; An Liu; Xusheng Du; Jie Bai; Mingwei Chen
Journal:  Am J Chin Med       Date:  2016-05-24       Impact factor: 4.667

9.  Carotid Body Ablation Abrogates Hypertension and Autonomic Alterations Induced by Intermittent Hypoxia in Rats.

Authors:  Rodrigo Del Rio; David C Andrade; Claudia Lucero; Paulina Arias; Rodrigo Iturriaga
Journal:  Hypertension       Date:  2016-07-05       Impact factor: 10.190

Review 10.  Carotid body chemoreceptors, sympathetic neural activation, and cardiometabolic disease.

Authors:  Rodrigo Iturriaga; Rodrigo Del Rio; Juan Idiaquez; Virend K Somers
Journal:  Biol Res       Date:  2016-02-26       Impact factor: 5.612

View more
  5 in total

1.  The risk of cardiovascular and cerebrovascular disease in overlap syndrome: a meta-analysis.

Authors:  Jiahuan Xu; Zhijing Wei; Xingjian Wang; Xiaomeng Li; Wei Wang
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

Review 2.  The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions.

Authors:  Habib Yaribeygi; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Diabetes Res       Date:  2020-11-17       Impact factor: 4.011

3.  Crucial Role of Stromal Interaction Molecule-Activated TRPC-ORAI Channels in Vascular Remodeling and Pulmonary Hypertension Induced by Intermittent Hypoxia.

Authors:  Sebastián Castillo-Galán; Bárbara Riquelme; Rodrigo Iturriaga
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

Review 4.  Sympathetic activation: a potential link between comorbidities and COVID-19.

Authors:  Andrea Porzionato; Aron Emmi; Silvia Barbon; Rafael Boscolo-Berto; Carla Stecco; Elena Stocco; Veronica Macchi; Raffaele De Caro
Journal:  FEBS J       Date:  2020-08-01       Impact factor: 5.542

5.  The potential role of the carotid body in COVID-19.

Authors:  Andrea Porzionato; Aron Emmi; Elena Stocco; Silvia Barbon; Rafael Boscolo-Berto; Veronica Macchi; Raffaele De Caro
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-05       Impact factor: 5.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.